logo rd

To highlight the excellence and expertise of French academic research teams.

Exchange around innovative projects.

Establishment of partnerships building, encourage international investments and support the competitiveness of France at a global level.

 

This one-day event comprises two phases

Presentation of cutting-edge findings by industrials and academics researchers (Round-tables discussions, academics pitches, presentation of public-private partnerships)

Morning

Presentation of cutting-edge findings by industrials and academics researchers (Round-tables discussions, academics pitches, presentation of public-private partnerships)

One-to-one meetings between the researchers of the academic or industrial field

Afternoon

One-to-one meetings between the researchers of the academic or industrial field

The main themes targeted by the International R&D Dating during the last years have been:

 

2009 : Neurosciences

2010 : Cardiovascular and metabolic diseases

2011 : Infectious diseases

2012 : Cancer

2013 : Inflamations

2015 : Rare diseases and personalized medicine 

2016 : Neurosciences and psychiatry

2018 : Immuno-Oncology

February 6th, 2018 in Palais d'léna 

r e d 

This year, the 8th International R&D Dating is organized under the theme «Immuno-oncology». It will take place in February 6th, 2018 in the Palais d’Iéna. Organized in partnership with AVIESAN’s cancer multi-agency thematic institute (ITMO Cancer), the French International R&D Dating will be attended by representatives from about 19 biomedical research firms* and about 40 academic researchers.

*Abbvie , AstraZeneca, BMS, Boehringer Ingelheim, GSK, Institut Mérieux, Institut Roche, Ipsen, Janssen, LFB, Merck, MSD, Novartis, Pfizer, Pierre Fabre, Roche Diagnostics, Sanofi, Servier, Takeda.